ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

XXII 22nd Century Group Inc

1.6495
0.0695 (4.40%)
May 01 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 203,097
Bid Price 1.60
Ask Price 1.65
News -
Day High 1.72

Low
1.45

52 Week Range

High
180.912

Day Low 1.59
Share Name Share Symbol Market Stock Type
22nd Century Group Inc XXII NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
0.0695 4.40% 1.6495 17:54:16
Open Price Low Price High Price Close Price Previous Close
1.65 1.59 1.72 1.65 1.58
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
1,306 203,097 US$ 1.64 US$ 333,999 - 1.45 - 180.912
Last Trade Type Quantity Price Currency
18:54:44 30 US$ 1.6483 USD

22nd Century Group Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
71.8M 43.78M - 32.2M -150.77M -3.44 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

22nd Century News

Date Time Source News Article
2/15/202415:30Edgar (US Regulatory)Form 8-K - Current report
2/14/202415:10Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial..
2/13/202415:30Edgar (US Regulatory)Form 8-K - Current report
1/25/202407:30Edgar (US Regulatory)Form 8-K - Current report
1/24/202415:31Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting..
1/24/202415:30Edgar (US Regulatory)Form 8-K - Current report
1/08/202419:04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
12/28/202315:30Edgar (US Regulatory)Form 8-K - Current report
12/21/202316:02Edgar (US Regulatory)Form 8-K - Current report
12/04/202306:07GlobeNewswire Inc.22nd Century Secures $3.2 Million to Date in Warrant..
12/01/202316:18Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statements
11/29/202309:55AllPennyStocks.comPharma Stock Up Big After Second Major Announcement This..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No XXII Message Board. Create One! See More Posts on XXII Message Board See More Message Board Posts

Historical XXII Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week1.681.971.521.76539,775-0.0305-1.82%
1 Month1.864.311.453.244,491,898-0.2105-11.32%
3 Months2.404.311.452.912,278,259-0.7505-31.27%
6 Months7.26088.6321.453.251,825,470-5.61-77.28%
1 Year168.00180.9121.4544.181,846,722-166.35-99.02%
3 Years957.60972.001.45340.431,924,898-955.95-99.83%
5 Years957.60972.001.45340.431,924,898-955.95-99.83%

22nd Century Description

22nd Century Group Inc is a US-based plant biotechnology company. It focuses on developing technology that allows the increase or decrease in the level of nicotine and other nicotinic alkaloids in tobacco plants and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. The company is engaged in the research and development of potentially less harmful or modified risk tobacco products and novel tobacco plant varieties. Other business activities of the company include manufacture, marketing, sales, and distribution of SPECTRUM and VLN proprietary cigarettes, contract manufacturing of third-party branded tobacco products, research and development of plant varieties of hemp/cannabis, the sale of branded proprietary tobaccos, and among others.

Your Recent History

Delayed Upgrade Clock